These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 10640455)
1. Fluorescent in situ hybridization study of c-myc oncogene copy number in prostate cancer. Mark HF; Samy M; Santoro K; Mark S; Feldman D Exp Mol Pathol; 2000 Feb; 68(1):65-9. PubMed ID: 10640455 [TBL] [Abstract][Full Text] [Related]
2. Fluorescence in situ hybridization study of HER-2/neu oncogene amplification in prostate cancer. Mark HF; Feldman D; Das S; Kye H; Mark S; Sun CL; Samy M Exp Mol Pathol; 1999 Jun; 66(2):170-8. PubMed ID: 10409446 [TBL] [Abstract][Full Text] [Related]
3. Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization. Liu HL; Gandour-Edwards R; Lara PN; de Vere White R; LaSalle JM Cancer J; 2001; 7(5):395-403. PubMed ID: 11693898 [TBL] [Abstract][Full Text] [Related]
4. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray. Skacel M; Ormsby AH; Pettay JD; Tsiftsakis EK; Liou LS; Klein EA; Levin HS; Zippe CD; Tubbs RR Hum Pathol; 2001 Dec; 32(12):1392-7. PubMed ID: 11774175 [TBL] [Abstract][Full Text] [Related]
5. Fluorescence in situ hybridization analysis of c-myc amplification in stage TNM prostate cancer in Japanese patients. Sato H; Minei S; Hachiya T; Yoshida T; Takimoto Y Int J Urol; 2006 Jun; 13(6):761-6. PubMed ID: 16834657 [TBL] [Abstract][Full Text] [Related]
6. Assessment of chromosomal trisomies in prostate cancer using fluorescent in situ hybridization. Mark HF; Feldman D; Das S; Samy M; Sun CL; Mark S Exp Mol Pathol; 1999 Oct; 67(2):109-17. PubMed ID: 10527762 [TBL] [Abstract][Full Text] [Related]
7. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Jenkins RB; Qian J; Lieber MM; Bostwick DG Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485 [TBL] [Abstract][Full Text] [Related]
8. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH. Wang ZR; Liu W; Smith ST; Parrish RS; Young SR Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442 [TBL] [Abstract][Full Text] [Related]
9. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression. Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839 [TBL] [Abstract][Full Text] [Related]
10. Assessment of chromosome 8 copy number in cervical cancer by fluorescent in situ hybridization. Mark HF; Feldman D; Samy M; Sun C; Das S; Mark S; Lathrop J Exp Mol Pathol; 1999 Jun; 66(2):157-62. PubMed ID: 10409444 [TBL] [Abstract][Full Text] [Related]
11. Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype. Williams K; Fernandez S; Stien X; Ishii K; Love HD; Lau YF; Roberts RL; Hayward SW Prostate; 2005 Jun; 63(4):369-84. PubMed ID: 15937962 [TBL] [Abstract][Full Text] [Related]
12. Relative copy number gain of MYC in diagnostic needle biopsies is an independent prognostic factor for prostate cancer patients. Ribeiro FR; Henrique R; Martins AT; Jerónimo C; Teixeira MR Eur Urol; 2007 Jul; 52(1):116-25. PubMed ID: 17070983 [TBL] [Abstract][Full Text] [Related]
13. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization. Qian J; Jenkins RB; Bostwick DG Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062 [TBL] [Abstract][Full Text] [Related]
14. Chromosome 8 numerical aberration and C-MYC copy number gain in bladder cancer are linked to stage and grade. Mahdy E; Pan Y; Wang N; Malmström PU; Ekman P; Bergerheim U Anticancer Res; 2001; 21(5):3167-73. PubMed ID: 11848469 [TBL] [Abstract][Full Text] [Related]
15. Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma. Shah US; Dhir R; Gollin SM; Chandran UR; Lewis D; Acquafondata M; Pflug BR Hum Pathol; 2006 Apr; 37(4):401-9. PubMed ID: 16564913 [TBL] [Abstract][Full Text] [Related]
16. [Relationship between chromosome 8 alterations and Gleason score in prostatic adenocarcinoma]. Zeng X; Wu SF; Xu Q; Xiao Y; Liu TH Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):523-8. PubMed ID: 17134545 [TBL] [Abstract][Full Text] [Related]
17. Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array. Rummukainen JK; Salminen T; Lundin J; Kytölä S; Joensuu H; Isola JJ Mod Pathol; 2001 Oct; 14(10):1030-5. PubMed ID: 11598174 [TBL] [Abstract][Full Text] [Related]
18. Detection of Her2/neu, c-MYC and ZNF217 gene amplification during breast cancer progression using fluorescence in situ hybridization. Shimada M; Imura J; Kozaki T; Fujimori T; Asakawa S; Shimizu N; Kawaguchi R Oncol Rep; 2005 Apr; 13(4):633-41. PubMed ID: 15756435 [TBL] [Abstract][Full Text] [Related]
19. [Correlation between malignancy of gastric cancer and c-myc DNA amplification or overexpression of c-myc protein]. Nakata B; Onoda N; Chung YS; Maeda K; Nishimura S; Yashiro M; Nitta A; Kubo T; Kato Y; Sowa M Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():176-9. PubMed ID: 7611785 [TBL] [Abstract][Full Text] [Related]
20. A molecularly genetic determination of prognostic factors of the prostate cancer and their relationships to expression of protein p27kip1. Dvorácková J; Uvírová M Neoplasma; 2007; 54(2):149-54. PubMed ID: 17319789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]